Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nicolò Zarotti, Fiona Eccles, Annabel Broyd, Christine Longinotti, Amanda Mobley & Jane Simpson. (2023) Third wave cognitive behavioural therapies for people with multiple sclerosis: a scoping review. Disability and Rehabilitation 45:10, pages 1720-1735.
Read now
Read now
Articles from other publishers (12)
Victor Longoria, Hannah Parcel, Bameelia Toma, Annu Minhas & Rana Zeine. (2022) Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination. Biomedicines 10:3, pages 539.
Crossref
Crossref
Sreedhar Palukuru, Suchitra S. Patil, R. Nagarathna, Amit Singh & K. S. Nibedita. (2021) Content Validity of an Integrated Yoga Module for Practice During Remission in Relapsing–Remitting Multiple Sclerosis Patients. Annals of Neurosciences 28:1-2, pages 29-38.
Crossref
Crossref
Claudio Solaro, Giulia Gamberini & Fabio Giuseppe Masuccio. (2018) Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment. CNS Drugs 32:2, pages 117-133.
Crossref
Crossref
Angela Senders, Kelsi Sando, Helané Wahbeh, Amie Peterson Hiller & Lynne Shinto. (2016) Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs. Journal of Health Psychology 21:8, pages 1676-1687.
Crossref
Crossref
Kim A. RogersMegan MacDonald. (2015) Therapeutic Yoga: Symptom Management for Multiple Sclerosis. The Journal of Alternative and Complementary Medicine 21:11, pages 655-659.
Crossref
Crossref
Daniel Hind, Jack Cotter, Anna Thake, Mike Bradburn, Cindy Cooper, Claire Isaac & Allan House. (2014) Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis. BMC Psychiatry 14:1.
Crossref
Crossref
Stephen S. Kirzinger, Jason Jones, Angela Siegwald & Andrew Bryce Crush. (2013) Relationship Between Disease-Modifying Therapy and Depression in Multiple Sclerosis. International Journal of MS Care 15:3, pages 107-112.
Crossref
Crossref
Rosa E Boeschoten, Joost Dekker, Bernard MJ Uitdehaag, Chris H Polman, Emma H Collette, Pim Cuijpers, Aartjan TF Beekman & Patricia van Oppen. (2012) Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial. BMC Psychiatry 12:1.
Crossref
Crossref
N.J. Patil, R. Nagaratna, C. Garner, N.V. Raghuram & R. Crisan. (2012) Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis—A prospective observational case series. Complementary Therapies in Medicine 20:6, pages 424-430.
Crossref
Crossref
Rosa E. Boeschoten, Magdalena M. Nieuwenhuis, Patricia van Oppen, Bernard M.J. Uitdehaag, Chris H. Polman, Emma H. Collette, Pim Cuijpers, Aartjan T.F. Beekman & Joost Dekker. (2012) Feasibility and outcome of a web-based self-help intervention for depressive symptoms in patients with multiple sclerosis: A pilot study. Journal of the Neurological Sciences 315:1-2, pages 104-109.
Crossref
Crossref
DM MillerB Weinstock-GuttmanD BourdetteX YouP FouldsRA Rudick. (2011) Change in quality of life in patients with relapsing–remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon β-1a. Multiple Sclerosis Journal 17:6, pages 734-742.
Crossref
Crossref
João Carlos Correia de Sa, Laura Airas, Emmanuel Bartholome, Nikolaos Grigoriadis, Heinrich Mattle, Celia Oreja-Guevara, Jonathan O’Riordan, Finn Sellebjerg, Bruno Stankoff, Karl Vass, Agata Walczak, Heinz Wiendl & Bernd C. Kieseier. (2011) Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Therapeutic Advances in Neurological Disorders 4:3, pages 139-168.
Crossref
Crossref